ELAVIL 10mg: NDMA impurity
Is your product affected? Check the DIN and lot number on your package against the list in Health Canada's official notice.
See affected DINs and lot numbers on Health Canada ↗Why it was recalled
Product safety
What you should do
- Patients can continue to take their medication as prescribed by their health care provider as there is no immediate risk in continuing to take the recalled medication. Stopping amitriptyline may lead to mild withdrawal symptoms.
- Contact your health care provider if you have taken a recalled product and you have concerns about your health. Ask your pharmacist if you are unsure whether you are taking a recalled product.
- Contact the company if you have questions about the recall:Apotex Inc. via Sedgwick by calling at 1-888-266-7914, or by email at apotex5117@sedgwick.comAA Pharma at 1-905-669-1565Report any health product-related side effects or complaints to Health Canada.
Other Recent Recalls
PegLyte Powder
PegLyte Powder: Affected lots may contain foreign matter
Type III2026-11-17
Low health risk
Taro-Candesartan tablets
TARO-CANDESARTAN: affected lots may contain Esomeprazole 20mg capsules
Type II2026-11-16
Moderate health risk
SECARIS NASAL GEL
SECARIS NASAL GEL: Affected lot may contain foreign matter
Type II2026-11-13
Moderate health risk
Recall data is sourced from Health Canada's Recalls and Safety Alerts open dataset. MedShort.ca is an independent tracking tool and does not provide medical advice — for questions about this recall, contact the manufacturer or your pharmacist, or read the full notice linked above.